Drug intelligence / Profile preview

Cepetor

Development stage
Unknown
Lead developer
Orion Pharma
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

**Cepetor** is a veterinary brand name for medetomidine hydrochloride, a potent synthetic α2-adrenergic receptor agonist formulated as a 1 mg/ml solution for injection primarily for dogs, and also cats. It provides reliable sedation and analgesia, making it suitable for clinical examinations, minor procedures, premedication for general anesthesia, and facilitating handling. Developed originally by Orion Pharma, it is marketed by companies including Modern Veterinary Therapeutics (Canada/US), CP Pharma, and historically Bioniche Life Sciences for distribution in regions like Australia. Effects are reversible with atipamezole (e.g., Revertor). Dosing typically ranges from 10-40 µg/kg IV/IM for premedication, with effects metabolized hepatically.

Brand names
Cepetor
02

Targets

ADRA2A (α2A)

Beyond the preview

Go deeper on Cepetor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cepetor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call